These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 577367)

  • 21. Causes of visual impairment in patients with ocular toxoplasmosis.
    Şahinoğlu Keşkek N; Ünal F; Cevher S; Keşkek ŞÖ
    J Infect Dev Ctries; 2017 Feb; 11(2):192-195. PubMed ID: 28248682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acquired toxoplasmic chorioretinitis.
    Saari M; Vuorre I; Neiminen H; Räisänen S
    Arch Ophthalmol; 1976 Sep; 94(9):1485-8. PubMed ID: 786226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies.
    Roizen N; Kasza K; Karrison T; Mets M; Noble AG; Boyer K; Swisher C; Meier P; Remington J; Jalbrzikowski J; McLeod R; Kipp M; Rabiah P; Chamot D; Estes R; Cezar S; Mack D; Pfiffner L; Stein M; Danis B; Patel D; Hopkins J; Holfels E; Stein L; Withers S; Cameron A; Perkins J; Heydemann P
    Pediatrics; 2006 Aug; 118(2):e379-90. PubMed ID: 16864640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Photocoagulation of active toxoplasmic retinochoroiditis.
    Ghartey KN; Brockhurst RJ
    Am J Ophthalmol; 1980 Jun; 89(6):858-64. PubMed ID: 6966892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biomicroscopic evaluation and photography of ocular toxoplasmosis.
    Hirokawa H; Trempe CL; Takahashi M; Kado M; Akiba J; Yoshida A
    Ann Ophthalmol; 1989 Oct; 21(10):379-83. PubMed ID: 2589741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Personal experience with treatment by photocoagulation of recurrent chorioretinitis of the macular region].
    Bonnet M; Pecoldowa K
    Arch Ophtalmol Rev Gen Ophtalmol; 1974 Oct; 34(10):669-80. PubMed ID: 4282226
    [No Abstract]   [Full Text] [Related]  

  • 27. Recurrent toxoplasmic retinochoroiditis. Significance of perilesional satellite dark dots seen by indocyanine green angiography.
    Bernasconi O; Auer C; Herbort CP
    Ocul Immunol Inflamm; 1997 Sep; 5(3):207-11. PubMed ID: 9326766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Preretinal neovessels in toxoplasmic uveitis].
    Gaudric A; Pelosse B; Coscas G
    J Fr Ophtalmol; 1983; 6(5):481-6. PubMed ID: 6195208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chorio-retinal toxoplasmosis: treatment outcomes, lesion evolution and long-term follow-up in a single tertiary center.
    Vishnevskia-Dai V; Achiron A; Buhbut O; Berar OV; Musika AA; Elyashiv SM; Hecht I
    Int Ophthalmol; 2020 Apr; 40(4):811-821. PubMed ID: 31792847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acquired toxoplasmic retinochoroiditis after platelet transfusions.
    Nelson JC; Kauffmann DJ; Ciavarella D; Senisi WJ
    Ann Ophthalmol; 1989 Jul; 21(7):253-4. PubMed ID: 2774432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retinal vascular involvement in acute toxoplasmic retinochoroiditis.
    Theodossiadis P; Kokolakis S; Ladas I; Kollia AC; Chatzoulis D; Theodossiadis G
    Int Ophthalmol; 1995; 19(1):19-24. PubMed ID: 8537191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Congenital ocular toxoplasmosis. Possible occurrence in siblings.
    Stern GA; Romano PE
    Arch Ophthalmol; 1978 Apr; 96(4):615-7. PubMed ID: 348171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Toxoplasmic retinochoroiditis: relapse vs choroidal neovascular membrane].
    Cordero-Coma M; Pérez E; Calleja S; García Ruiz de Morales JM
    Arch Soc Esp Oftalmol; 2010 Dec; 85(12):410-3. PubMed ID: 21354510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporal changes in a giant macular hole formed secondary to toxoplasmic retinochoroiditis.
    Tanaka R; Obata R; Sawamura H; Ohtomo K; Kaburaki T
    Can J Ophthalmol; 2014 Oct; 49(5):e115-8. PubMed ID: 25284113
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical entities in "uveitis". An approach to the study of intraocular inflammation.
    Maumenee AE
    Am J Ophthalmol; 1970 Jan; 69(1):1-27. PubMed ID: 4904197
    [No Abstract]   [Full Text] [Related]  

  • 36. Aqueous chamber taps in toxoplasmic chorioretinitis.
    Kijlstra A; Breebaart AC; Baarsma GS; Bos PJ; Rothova A; Luyendijk L; Fortuin M; Schweitzer NJ
    Doc Ophthalmol; 1986 Dec; 64(1):53-8. PubMed ID: 3582102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical features and prognosis in ocular toxoplasmosis.
    Atmaca LS; Simsek T; Batioglu F
    Jpn J Ophthalmol; 2004; 48(4):386-91. PubMed ID: 15295668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review for disease of the year: differential diagnosis of ocular toxoplasmosis.
    Vasconcelos-Santos DV; Dodds EM; Oréfice F
    Ocul Immunol Inflamm; 2011 Jun; 19(3):171-9. PubMed ID: 21595533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The serology of toxoplasmosis in uveitis].
    Pop R; Oancea I; Literat A; Vlăduţiu C; Abderahim A; Bagoşi P; Clepee E
    Oftalmologia; 1992; 36(1):47-52. PubMed ID: 1520669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Absence of specific clinical symptoms in toxoplasmic chorioretinitis].
    Haut J; Maire-Rateau B; Dhumeaux M; Limon S
    Arch Ophtalmol Rev Gen Ophtalmol; 1973 May; 33(5):413-6. PubMed ID: 4270421
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.